Se-Hoon Lee, Ph.D.

Affiliations: 
2011 University of Texas at Austin, Austin, Texas, U.S.A. 
Area:
Nanotechnology, Electronics and Electrical Engineering
Google:
"Se-Hoon Lee"

Parents

Sign in to add mentor
Sanjay K. Banerjee grad student 2011 UT Austin
 (Process Integration and Performance Evaluation of Germanium-based Quantum Well Channel MOSFETs for Sub-22nm Node Digital CMOS Logic Technology.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Keam B, Lee KW, Lee SH, et al. (2019) A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma. The Oncologist
Park SE, Noh JM, Kim YJ, et al. (2018) EGFR Mutation is Associated with Short Progression Free Survival in Patients with Stage III Non-Squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy. Cancer Research and Treatment : Official Journal of Korean Cancer Association
Lee SH, Lee B, Shim JH, et al. (2018) Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients. Cancer Research and Treatment : Official Journal of Korean Cancer Association
Park BJ, Cho JH, Lee JH, et al. (2018) Temporal and regional distribution of initial recurrence site in completely resected N1-stage II lung adenocarcinoma: The effect of postoperative adjuvant chemotherapy. Lung Cancer (Amsterdam, Netherlands). 117: 7-13
Reynolds KL, Bedard PL, Lee SH, et al. (2017) A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer. Bmc Cancer. 17: 646
Cho M, Ahn S, Hong M, et al. (2017) Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences. Oncotarget
Cho KM, Keam B, Kim TM, et al. (2016) Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure. The Korean Journal of Internal Medicine
Park S, Park S, Lee SH, et al. (2016) Pretreatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancer. Cancer Biomarkers : Section a of Disease Markers. 16: 425-33
Sim SH, Beom SH, Ahn YO, et al. (2016) Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors. Thoracic Cancer. 7: 161-6
Park S, Park S, Lee SH, et al. (2016) Nutritional status in the era of target therapy: poor nutrition is a prognostic factor in non-small cell lung cancer with activating epidermal growth factor receptor mutations. The Korean Journal of Internal Medicine
See more...